Astellas Pharma Inc  

(Public, TYO:4503)   Watch this stock  
Find more results for 4503
5,410.00
-70.00 (-1.28%)
May 24 - Close
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 5,150.00 - 5,600.00
52 week 3,020.00 - 6,010.00
Open 5,540.00
Vol / Avg. 3.55M/196.00
Mkt cap 2.44T
P/E 30.15
Div/yield 65.00/2.40
EPS 179.42
Shares 451.18M
Beta     -
Inst. own     -
Aug 1, 2013
Q1 2014 Astellas Pharma Inc Earnings Release Add to calendar
Jun 19, 2013
Astellas Pharma Inc Annual Shareholders Meeting (Japanese) Add to calendar
May 14, 2013
Full Year 2013 Astellas Pharma Inc Earnings Presentation and Conference Call (Japanese)
  

Key stats and ratios

Q1 (Mar '13) 2013
Net profit margin -0.71% 8.24%
Operating margin -1.84% 11.58%
EBITD margin - 21.05%
Return on average assets -0.50% 5.82%
Return on average equity -0.68% 7.97%
Employees 17,085 -
Carbon Disclosure Rating - 70/100

Address

2-3-11, Nihonbashihon-cho
CHUO-KU, TKY 103-8411
Japan
+81-3-32443000 (Phone)

Website links

External links

Discussion Group - Google Finance

Description

Astellas Pharma Inc. is a Japan-based company mainly engaged in the pharmaceutical business. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea and Taiwan, through its subsidiaries. Its main products include immunosuppressive drug Prograf, overactive bladder agent Vesicare, Protopic ointment for atopic dermatitis, Harnal for prostatic and urethral smooth muscle, and antimycotic agent Funguard, among others. It also provides pharmaceutical products for gastritis, chronic hepatitis C, irritable bowel syndrome, osteoporosis, hypertension, schizophrenia, rheumatoid arthritis, agrypnia, atopic dermatitis and other diseases.

Officers and directors

Masafumi Nogimori Chairman of the Board, Representative Director
Age: 65
Yoshihiko Hatanaka President, Representative Director
Age: 56
Yasuo Ishii Vice Chairman of the Board, Representative Director
Age: 65
Masao Yoshida Senior Executive Officer, President and CEO of Subsidiaries
Yoshiro Miyokawa Vice President, Representative Director
Age: 60
Yukihiko Sato Executive Officer, Chief Director of Sales
Yoshiaki Nakashima Executive Officer, Director of Human Resources
Masaki Doi Executive Officer, Manager of Vaccine Business Promotion Office
Haruhisa Hirosaki Executive Officer, Chief Director of Development
Takahisa Iizuka Executive Officer, Director of Sales Promotion